Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat

Table 1 Effect of lycopene on serum liver function markers and blood lipid levels

Group	ALT (IU/L)	AST (IU/L)	TG (mmol/L)	TC (mmol/L)
Control	16.72 ± 2.62	60.65 ± 6.28	0.52 ± 0.04	0.81 ± 0.06
Model	61.25 ± 13.55b	162.17 ± 35.53b	1.38 ± 0.21b	3.04 ± 0.72b
Ly 5 mg/kg	30.90 ± 3.84c	95.91 ± 13.65c	1.02 ± 0.10	2.31 ± 0.24
Ly 10 mg/kg	26.33 ± 2.06d	88.53 ± 9.18d	0.75 ± 0.06c	2.00 ± 0.12c
Ly 20 mg/kg	20.77 ± 3.52d	78.44 ± 9.79d	0.59 ± 0.03d	1.83 ± 0.15d

Data are expressed as mean ± SD (n = 12) for each group.

^bP < 0.01 vs control group;

^cP < 0.05,

^dP < 0.01 vs model group. Ly: Lycopene; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TG: Triglycerides; TC: Total cholesterol.